首页
订购/客服:400-666-5481

CCT128930,AKT2 抑制剂

    
98%

4-(4-chlorobenzyl)-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidin-4-amine

源叶(MedMol)
S81062 一键复制产品信息
885499-61-6
C18H20ClN5
341.84
CCT128930
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S81062-5mg
98%

¥808.00

10 - - - -
S81062-10mg
98%

¥1313.00

10 - - - -
S81062-25mg
98%

¥2818.00

6 - - - -
S81062-50mg
98%

¥4301.00

3 - - - -
S81062-100mg
98%

¥6674.00

5 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: CCT128930 is a ATP-competitive and selective inhibitor of AKT (IC50=6 nM for AKT2). CCT128930 has 28-fold selectivity over the closely related PKA kinase (IC50=168 nM) through the targeting of Met282 of AKT (Met173 of PKA-AKT chimera), as well as 20-fold selectivity over p70S6K (IC50=120 nM). Antitumor activity.
靶点: Akt2:6 nM (IC50);p70S6K:120 nM (IC50);PKA:168 nM (IC50);Autophagy;Apoptosis;Akt; PKA; S6Kinase; Autophagy
体内研究: CCT128930 (25 or 40 mg/kg; i.p. daily or twice daily for 5 days) shows antitumor activities in U87MG and BT474 human breast cancer xenografts.Summary of the pharmacokinetic parameters of CCT128930 (25 mg/kg) in CrTacNCr-Fox1nu mice
参考文献: 1. Yap TA et al. Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930. Mol Cancer Ther. 2011 Feb;10(2):360-71. 2. Wang FZ, et al. CCT128930 induces cell cycle arrest, DNA damage, and autophagy independent of Akt inhibition. Biochimie. 2014;103:118-125.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.925 ml 14.627 ml 29.253 ml
5 mM 0.585 ml 2.925 ml 5.851 ml
10 mM 0.293 ml 1.463 ml 2.925 ml
50 mM 0.059 ml 0.293 ml 0.585 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×